Nexus searches hundreds of millions of papers and returns not just what the literature says — but why the debate looks the way it does. Methodology conflicts. Funding bias. Research gaps. All surfaced automatically.
Strong evidence from 3 meta-analyses (2021–2023, n=4,200) supports benefit in secondary prevention. Disagreement stems from primary prevention cohorts where effect sizes are smaller and dose-response relationships are unclear.
Every paper contributes to a picture. Nexus reconstructs that picture so you can see the shape of scientific agreement — not just the headline result.
When multiple independent replications point the same direction, Nexus shows you the strength and breadth of agreement — and which domains are tested.
When studies contradict, Nexus doesn't flatten the nuance. It surfaces the disagreement, explains what's driving it, and identifies which papers you can trust more.
Not every question has an answer yet. Nexus distinguishes between genuinely contested science and questions that simply haven't been studied properly.
Every other tool tells you that studies conflict. Nexus explains why — so you can judge the literature yourself and decide where to push the field forward.
Automatically identifies when studies disagree because of sample size, measurement instruments, population differences, or statistical approaches.
Cross-references study funding sources. When industry-funded studies consistently reach different conclusions, you see it — with the numbers.
Surface when evidence comes predominantly from specific populations and what that means for generalizability to your patient, context, or country.
Track how scientific consensus has evolved. When did the field flip? What new evidence drove the change? See it mapped over time.
Nexus doesn't just show you what exists — it identifies what's missing. This is where the real contribution lies: finding the space where your work can move the field forward.
Where two or more well-developed fields meet but haven't been combined? Nexus finds these — they often generate the most novel findings.
Shows you which demographics are over- or under-represented in current evidence, and what that means for your study's external validity.
Identifies where the dominant study design (e.g., RCTs only) has left qualitative or mixed-methods questions completely unanswered.
Surfaced when the last study on a specific sub-question is more than 5 years old — the field may have moved on without a systematic update.
Every tool tells you what the literature says. None explain why the debate looks the way it does. That gap is real and unaddressed.
2 million+ papers published annually. Manual literature review can't scale. AI can — if you build the right causal layer on top of the data.
Living review formats are gaining traction (Living Evidence Maps, COVID-NMA). The infrastructure is ready. The synthesis layer is missing.
GDPR-compliant, EU-based. French Ministry of Higher Education just backed OpenAlex — the data infrastructure Nexus runs on. Timing is good.
Nexus turns millions of papers into a structured, honest picture of scientific knowledge — consensus, debate, and gaps — so your research starts where the field actually is, not where you assume it is.
Free to start. No credit card required.